ProfileGDS5678 / 1447596_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 46% 45% 44% 44% 47% 48% 45% 44% 45% 48% 44% 51% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.145747
GSM967853U87-EV human glioblastoma xenograft - Control 23.063146
GSM967854U87-EV human glioblastoma xenograft - Control 33.0396745
GSM967855U87-EV human glioblastoma xenograft - Control 42.9564144
GSM967856U87-EV human glioblastoma xenograft - Control 52.9660444
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2171947
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1967548
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0459945
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9890544
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0382945
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1341148
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9891644
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2243551
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0602245